Cell & Gene Therapy International Europe 2026
Conference Details
Date: 03 November 2026
Time: 08:00
Duration: 3 days
Location: Berlin, Germany
Cost: £ 999 - £ 1399
Organiser: Informa Connect
Conference Description
From Breakthrough Science to Industrial Reality: Scaling Affordable, Accessible Cell and Gene Therapies
Go beyond theory: Delivering real gains in manufacturing efficiency, commercial scalability, and cost of goods reduction for ATMPs.
Learn from the Best: Gain Actionable Insights from the Leading Minds Driving Cell and Gene Therapy Manufacturing Forward
Cell & Gene Therapy International Europe bring together industry leaders shaping the future of advanced therapies. The event features the latest research, regulatory insights, and manufacturing expertise tailored to the European landscape.
Smart Manufacturing Technologies Transforming Cell & Gene Therapy
From data to decisions in real time: Harness AI, automation, robotics, and next-generation PAT technologies to drive faster, smarter, and more scalable production.
Scaling Cell & Gene Therapy Manufacturing Without Compromising Quality
Tackle the COGS crisis head-on: Unlock actionable insights from real-world case studies that enhance manufacturing efficiency, enable scalability, reduce costs, and ensure quality control across autologous, allogeneic, and AAV therapies.
Advanced Analytics & Product Characterisation for Faster Regulatory Success
Accelerate regulatory approvals through innovative analytics, advanced process control, and comprehensive characterisation whilst maintaining uncompromising quality standards.
From Early-Stage Development to Commercial-Scale Manufacturing
Discover what works: Strategies and lessons from successful discovery-to-commercialisation journeys in cell and gene therapy.
Advancing Cell & Gene Therapy Through Next-Generation R&D
Uncover the latest R&D advances, including in vivo CAR-T, solid tumour targeting, and emerging therapeutic modalities that expand treatment access to broader patient populations.
Manufacturing & Delivery Innovations Advancing In Vivo CAR-T
Navigate the complete pathway to commercial success: Master manufacturing, CMC, regulatory, and delivery strategies that scale in vivo CAR-T therapies from concept to clinical reality.
© EuroJobsites 2026